Genmab — December 2016
-
ja super nyhed. I sin tid var det faktisk lidt specielt da Japan ret sent kom med i Pollux, hvilket efter hukommelsen vist nok fik Pollux til at vare lidt længere end ellers nødvendigt, og i øvrigt var det en medvirken med en hel del klinikker. Siden har der været to meget små japanske studier i fase 1, så det har fremstået som noget i tidlig fase.
-
ja
-
før
-
no problem
-
"Choose the cancer center that’s right for your cancer" -by Kathy Giusti : https://www.statnews.com/2016/12/16/cancer-center-treatment/
-
RVd vs. RVD plus daratumumab study, Dr. Peter Voorhees hopes to have all 40 participating US centres enrolled by end Q1 '17 http://www.myelomacrowd.org/clinical-trial-adding-daratumumab-to-the-frontline-for-newly-diagnosed-myeloma-patients/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind